Want to see SG:Z4D full AI Analyst Report?
Top Page
Medi Lifestyle Limited
(SGX:Z4D)
Select Model
Select Model
Rating:46Neutral
Price Target:
S$0.09
▲(770.00% Upside)
Action:Reiterated
Date:08/19/26
The score is primarily held down by weak financial performance (sharp TTM revenue contraction, persistent losses, ongoing cash burn, and negative equity). Technical indicators provide some offset due to strong momentum and price above key moving averages, but valuation remains challenged because losses drive a negative P/E and no dividend yield is provided.
Positive Factors
Improving Cash Burn
Cash burn has improved versus some prior annual periods, which may indicate early progress in liquidity management. However, operating and free cash flow remain negative, so this is a limited rather than self-sustaining strength.
Negative Factors
Sharp Revenue Contraction
A 47.8% TTM revenue decline signals substantial deterioration in demand, scale, or execution. Prolonged contraction can weaken operating leverage, reduce funding capacity, and make a return to sustainable profitability more difficult.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving Cash Burn
Cash burn has improved versus some prior annual periods, which may indicate early progress in liquidity management. However, operating and free cash flow remain negative, so this is a limited rather than self-sustaining strength.
Read all positive factors
Medi Lifestyle Limited (Z4D) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$47.07M
Dividend YieldN/A
Average Volume (3M)1.45M
Price to Earnings (P/E)―
Beta (1Y)0.25
Revenue Growth-86.50%
EPS Growth32.35%
CountrySG
Employees156
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)-0.01
Shares Outstanding567,173,030
10 Day Avg. Volume2,787,930
30 Day Avg. Volume1,454,443
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)-1.55
Price to Sales (P/S)1.92
P/FCF Ratio-2.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Medi Lifestyle Limited Business Overview & Revenue Model
Company Description
Medi Lifestyle Limited is an investment holding firm that offers a range of services, including placement solutions, across Malaysia, Singapore, and China. The company's operations are divided into three core segments: Healthcare, Outsourced Servi...
How the Company Makes Money
null...
Medi Lifestyle Limited Financial Statement Overview
Summary
Income Statement
9
Very Negative
Balance Sheet
12
Very Negative
Cash Flow
10
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 697.95K | 4.42M | 1.84M | 1.94M | 2.40M | 1.40M |
| Gross Profit | -57.51K | -54.02K | -211.71K | 154.33K | 92.91K | 491.58K |
| EBITDA | -3.71M | -3.71M | -4.69M | -6.18M | -3.49M | -9.15M |
| Net Income | -4.14M | -3.86M | -5.34M | -7.19M | -4.30M | -23.72M |
Balance Sheet | ||||||
| Total Assets | 5.10M | 845.76K | 1.86M | 811.50K | 2.18M | 4.03M |
| Cash, Cash Equivalents and Short-Term Investments | 4.73M | 261.30K | 1.07M | 106.11K | 510.06K | 1.22M |
| Total Debt | 1.24M | 1.20M | 1.57M | 3.84M | 3.53M | 4.96M |
| Total Liabilities | 12.67M | 6.33M | 3.45M | 10.03M | 10.89M | 9.96M |
| Stockholders Equity | -7.57M | -5.48M | -1.59M | -9.22M | -8.71M | -5.93M |
Cash Flow | ||||||
| Free Cash Flow | -2.40M | -3.98M | -6.54M | -6.83M | -2.31M | -4.31M |
| Operating Cash Flow | -2.39M | -3.98M | -6.54M | -6.81M | -2.12M | -4.11M |
| Investing Cash Flow | -4.00K | -3.85K | 0.00 | -24.83K | -191.16K | -197.61K |
| Financing Cash Flow | 5.82M | 3.18M | 7.54M | 6.38M | 1.44M | 5.02M |
Medi Lifestyle Limited Peers Comparison
UnderperformOutperform
Sector (51)
SG:Z4D
Medi Lifestyle Limited
0.08
0.07
710.00%
SG:505
Asiamedic Limited
0.02
<0.01
26.67%
SG:FRQ
Singapore Paincare Holdings Limited
0.06
-0.10
-62.03%
SG:OTX
Medinex Ltd.
0.23
0.02
11.94%
SG:PRH
Livingstone Health Holdings Limited
0.02
<0.01
14.29%
SG:V8Y
Quantum Healthcare Ltd.
―
―
―
Medi Lifestyle Limited Corporate Events
Medi Lifestyle Raises S$8.75 Million via Share Placement to Fund Growth
Aug 18, 2026
Medi Lifestyle Limited has launched a placement of 178,588,000 new ordinary shares at S$0.049 each to raise gross proceeds of about S$8.75 million. The new shares will represent roughly 23.95% of the enlarged share capital and are intended to broa...
Medi Lifestyle Moves into Dental AI with Planned 60% Stake in EM2AI
Aug 16, 2026
Medi Lifestyle Limited has signed a non-binding term sheet to acquire a 60% stake in EM2AI Pte. Ltd. from Q M Dental Group, marking its entry into technology-enabled healthcare. EM2AI is a Singapore-based medical technology company offering an AI...
Medi Lifestyle Details Use of Rights Issue Proceeds and Retains Funds for Growth
Jul 9, 2026
Medi Lifestyle Limited has raised approximately S$3.56 million in net proceeds from a renounceable non-underwritten rights issue, after deducting about S$220,000 in expenses. The company has applied part of these funds toward setting off a shareho...
Medi Lifestyle’s Oversubscribed Rights Issue Raises S$3.56 Million for Working Capital
Jul 2, 2026
Medi Lifestyle Limited has completed a renounceable non-underwritten rights issue, offering new ordinary shares at S$0.02 each on a one-for-two basis, which saw strong investor interest. Valid acceptances and excess applications totalled 409,909,9...
Medi Lifestyle launches non-underwritten rights issue to raise fresh equity
Jun 16, 2026
Medi Lifestyle Limited has launched a renounceable, non-underwritten rights issue of up to 189,051,006 new shares at S$0.02 each, on the basis of one rights share for every two existing shares held as at the designated record date. The company has...
Medi Lifestyle Locks In Shareholder Support and Debt Set-Off in Rights Issue
Jun 4, 2026
Medi Lifestyle Limited has detailed the terms of its previously announced renounceable non-underwritten rights issue of up to 189,051,006 new shares at S$0.02 each, offered on the basis of one rights share for every two existing shares. The compan...
Medi Lifestyle AGM Backs Board Slate, Higher Directors’ Fees and Auditor Reappointment
May 29, 2026
Medi Lifestyle Limited held its annual general meeting in Singapore on 30 April 2026, where shareholders voted by poll on key corporate matters in line with Catalist rules. The meeting proceeded without shareholder questions, with the audited fina...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.